<DOC>
	<DOCNO>NCT01279434</DOCNO>
	<brief_summary>Nonalcoholic fatty liver disease ( NAFLD ) spectrum hepatic pathology , range simple steatosis , steatohepatitis , cirrhosis . Nonalcoholic steatohepatitis ( NASH ) advance form disease steatosis accompany hepatocyte injury well infiltration inflammatory cell . Since , vitamin E PTX find improve NASH use alone , combination two expect give good result target two different pathogenetic mechanism ( cytokine amplification oxidative stress ) NASH patient . This open label , prospective , randomize study . The diagnosis NAFLD make basis Ultrasonographic finding suggestive fatty liver presence insulin resistance feature metabolic syndrome . Subsequently histologic confirmation diagnosis NASH make case .</brief_summary>
	<brief_title>Vitamin E Versus Vitamin E Plus Pentoxiphyllin Patients With Nonalcoholic Steatohepatitis : A Prospective Randomized Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Diagnosis NAFLD ultrasonographic Presence Insulin resistance Histological confirmation NASH Increased transaminase ( &gt; 1.5 upper limit normal [ ULN ] ) Patients alcohol &gt; 20g/ day Other know liver disease Medications know induce fatty liver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>